interleukin 5 (R&D Systems)
Structured Review
Interleukin 5, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 35 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+il+5+quantikine+elisa+kit/Human+IL-5+Quantikine+ELISA+Kit/pmc12932558-94-18-21
Average 94 stars, based on 35 article reviews
Images
Related Articles
Enzyme-linked Immunosorbent Assay:Article Title: Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis. Article Snippet: Background There is a lack of studies on the effect of tacrolimus on eosinophils and related molecules including eotaxin, CCR3, RANTES and interleukin (IL)-5.. Objectives To investigate the effects of tacrolimus on in vivo eosinophil counts and on the related molecules eotaxin, CCR3, RANTES and IL-5 in patients with atopic dermatitis (AD).. Methods Lesional skin specimens and sera were obtained from 15 patients with AD and from 15 normal controls. Article Title: NS-229, a novel Janus kinase 1 inhibitor, ameliorates eosinophilic vasculitis in an ovalbumin-induced mouse model by modulating multiple cytokine signaling pathways Article Snippet: Methyl (1-{[6-{[(1S)-1-cyclopropylethyl]amino}-2-(pyrazolo[5,1-b][1,3]thiazol-7-yl)pyrimidin-4-yl] carbonyl}piperidin-4-yl)carbamate mono(4-methylbenzenesulfonate) monohydrate (NS-229) is a novel Janus kinase 1 inhibitor currently being evaluated in a phase 2 global study (NCT06046222) for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA).. We investigated the nonclinical efficacy of NS-229 to support its therapeutic use in treating EGPA.. Its effects were investigated in human peripheral blood eosinophils, human peripheral blood mononuclear cells, and a mouse model of eosinophilic vasculitis induced by ovalbumin. Article Title: Metabolites of intestinal microflora upregulate microRNA-200c-3p expression level to suppress airway epithelial inflammation via the IL6ST/JNK/STAT3 signaling pathway Article Snippet: Anti-GAPDH antibody (1:500; 5174T; Cell Signaling Technology, Inc.) was used as the internal reference. .. The supernatant of each group was collected after the 16HBE cells were stimulated with HDM for 24 h. ELISA kits were used to determine the IL-5 ( Article Title: CTNNAL1 enhances glucocorticoid sensitivity in HDM-induced asthma mouse model through deactivating hsp90 signaling pathway. Article Snippet: Aims: Adhesion molecules play vital roles in the induction of airway hyperresponsiveness (AHR) or airway inflammation.. The down-regulation of catenin alpha-like 1 (CTNNAL1) in the bronchial epithelial cells of asthma patients and mice models has been noted in our previous study.. In this work, we further explore the underlying mechanism of CTNNAL1 in asthma. Produced:Article Title: NS-229, a novel Janus kinase 1 inhibitor, ameliorates eosinophilic vasculitis in an ovalbumin-induced mouse model by modulating multiple cytokine signaling pathways Article Snippet: Methyl (1-{[6-{[(1S)-1-cyclopropylethyl]amino}-2-(pyrazolo[5,1-b][1,3]thiazol-7-yl)pyrimidin-4-yl] carbonyl}piperidin-4-yl)carbamate mono(4-methylbenzenesulfonate) monohydrate (NS-229) is a novel Janus kinase 1 inhibitor currently being evaluated in a phase 2 global study (NCT06046222) for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA).. We investigated the nonclinical efficacy of NS-229 to support its therapeutic use in treating EGPA.. Its effects were investigated in human peripheral blood eosinophils, human peripheral blood mononuclear cells, and a mouse model of eosinophilic vasculitis induced by ovalbumin. |

